# BioCardia to Participate in a Fireside Chat at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
Canonical URL: https://biopharmsignal.com/news/BCDA/biocardia-to-participate-in-a-fireside-chat-at-the-alliance-global-partners-a-g--7891d68a
Ticker: BCDA
Company: BioCardia
Source: BioCardia
Published: 2026-05-19 12:00 EST
## Summary

BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the...

## Article Body
BioCardia, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, will participate virtually in a fireside chat at A.G.P.'s Healthcare Company Showcase.

Fireside Chat Details:

Time: 11:40 AM ET

Date: Wednesday, May 20, 2026

Investors can register for the conference and view the fireside chat here .

About BioCardia ®

BioCardia, Inc. , headquartered in Sunnyvale, California, is developing cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease. CardiAMP ® autologous and CardiALLO™ allogeneic cell therapies are the Company’s biotherapeutic platforms for the treatment of heart disease. These therapies are enabled by its Helix™ biotherapeutic delivery and Morph ® vascular navigation product platforms. For more information visit: www.BioCardia.com .
## Recent Company News
- 2026-06-18 12:00 EST — [BioCardia Letter to Stockholders on 2026 Priorities and Strategic Opportunities](https://biopharmsignal.com/news/BCDA/biocardia-letter-to-stockholders-on-2026-priorities-and-strategic-opportunities-187b0df4) — Source: BioCardia
- 2026-06-08 12:00 EST — [BioCardia Announces $4.4 Million Financing](https://biopharmsignal.com/news/BCDA/biocardia-announces-4-4-million-financing-0937a2f3) — Source: BioCardia
- 2026-06-05 12:00 EST — [FDA Confirms CardiAMP HF II May Support Premarket Approval of CardiAMP Cell Therapy for Ischemic HFrEF](https://biopharmsignal.com/news/BCDA/fda-confirms-cardiamp-hf-ii-may-support-premarket-approval-of-cardiamp-cell-ther-336b7f77) — Source: BioCardia
- 2026-05-28 12:00 EST — [BioCardia Announces Japan PMDA Record Of Advice Supports Regulatory Submission For Approval Of CardiAMP Cell Therapy For Ischemic Heart Failure](https://biopharmsignal.com/news/BCDA/biocardia-announces-japan-pmda-record-of-advice-supports-regulatory-submission-f-6bb5419d) — Source: BioCardia
- 2026-05-21 12:00 EST — [BioCardia Announces CardiAMP Chronic Myocardial Ischemia Trial Results Presented at EuroPCR Showed Durable Improvements in Exercise Tolerance with Reduced Angina Frequency](https://biopharmsignal.com/news/BCDA/biocardia-announces-cardiamp-chronic-myocardial-ischemia-trial-results-presented-fd6856cf) — Source: BioCardia
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)